Understanding sex-related differences in healthcare utilisation among patients with inflammatory arthritis: a population-based study
Tarannum S, Widdifield J, Wu CF, Johnson SR, Rochon P, Eder L. Ann Rheum Dis. 2023; 82:283-91. Epub 2022 Sep 16.
Publications
Identification of early onset dementia in population-based health administrative data: a validation study using primary care electronic medical records
Jaakkimainen L, Duchen R, Lix L, Al-Azazi S, Yu B, Butt D, Park SB, Widdifield J. J Alzheimers Dis. 2022; 89(4):1463-72. Epub 2022 Sep 1.
Evaluating the time-varying risk of hypertension, cardiac events, and mortality following Kawasaki disease diagnosis
Lee JJY, Feldman BM, McCrindle BW, Li P, Yeung RS, Widdifield J. Pediatr Res. . 2023; 93(5):1439-46. Epub 2022 Aug 24.
Survival after surgery for spinal metastases: a population-based study
Bhanot K, Widdifield J, Huang A, Paterson JM, Shultz DB, Finkelstein J. Can J Surg. 2022; 65(4):E512-8. Epub 2022 Aug 2.
A population-based study evaluating retention in rheumatology care among patients with rheumatoid arthritis
Barber CEH, Lacaille D, Croxford R, Barnabe C, Marshall DA, Abrahamowicz M, Xie H, Avina-Zubieta JA, Esdaile JM, Hazlewood G, Faris P, Katz S, MacMullan P, Mosher D, Widdifield J. ACR Open Rheumatol. 2022; 4(7):613-22. Epub 2022 May 5.
Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis
Widdifield J, Kwong JC, Chen S, Eder L, Benchimol EI, Kaplan GG, Hitchon C, Aviña-Zubieta JA, Lacaille D, Chung H, Bernatsky S. Lancet Rheumatol. 2022; Apr 14 [Epub ahead of print].
Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
Kuenzig ME, Widdifield J, Bernatsky S, Kaplan GG, Benchimol EI. Lancet Gastroenterol Hepatol. 2022; 7(4):288-9. Epub 2022 Feb 22.
COVID-19 hospitalizations, intensive care unit stays, ventilation and death among patients with immune mediated inflammatory diseases compared to controls
Eder L, Croxford R, Drucker AM, Mendel A, Kuriya B, Touma Z, Johnson SR, Cook R, Bernatsky S, Haroon N, Widdifield J. J Rheumatol. 2022; 49(5):523-30. Epub 2022 Feb 1.
COVID-19 vaccination uptake among individuals with immune-mediated inflammatory diseases in Ontario, Canada between December 2020 and October 2021: a population-based analysis
Widdifield J, Eder L, Chen S, Kwong JC, Hitchon C, Lacaille D, Aviña-Zubieta JA, Svenson LW, Bernatsky S. J Rheumatol. 2022; 49(5):531-6. Epub 2022 Jan 15.
Understanding COVID-19 risk in patients with immune mediated inflammatory diseases: a population-based analysis of SARS-CoV-2 testing
Eder L, Croxford R, Drucker AM, Mendel A, Kuriya B, Touma Z, Johnson SR, Cook R, Bernatsky S, Haroon N, Widdifield J. Arthritis Care Res (Hoboken). 2023; 75(2):317-25. Epub 2021 Sep 6.